Keith W. Pfeil - Jul 19, 2021 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
SVP, Chief Financial Officer
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Jul 19, 2021
Transactions value $
-$23,852
Form type
4
Date filed
7/20/2021, 04:20 PM
Previous filing
Jul 6, 2021
Next filing
Aug 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $41.4K +834 $49.65 834 Jul 19, 2021 Direct
transaction GMED Class A Common Stock Sale -$65.3K -834 -100% $78.25 0 Jul 19, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -834 -3.85% $0.00 20.8K Jul 19, 2021 Class A Common Stock 834 $49.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F2 These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.